Phoenix BioMedical Campus Phase I REIT, LLC is a real estate fund based in Chicago, Illinois. According to its most recent Form D, filed Jan 13, 2021, it has sold $125,000 of interests to 125 investors since its first sale in Jan 2021. The minimum investment it accepts from an outside investor is $1,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Fran Federman; Thomas Shin; Douglas Johnson.
- Total raised
- $125,000Cumulative sales reported on Form D
- Investors
- 125
- First sale
- Jan 1, 2021
- Minimum investment
- $1,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Fran Federman; Thomas Shin; Douglas Johnson
- Latest Form D
- Jan 13, 2021
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Phoenix BioMedical Campus Phase I REIT, LLC
What is the minimum investment for Phoenix BioMedical Campus Phase I REIT, LLC?
According to its latest Form D, filed Jan 13, 2021, the minimum investment Phoenix BioMedical Campus Phase I REIT, LLC accepts from an outside investor is $1,000.
Who can invest in Phoenix BioMedical Campus Phase I REIT, LLC?
Phoenix BioMedical Campus Phase I REIT, LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Phoenix BioMedical Campus Phase I REIT, LLC raised?
Phoenix BioMedical Campus Phase I REIT, LLC reports $125,000 sold from 125 investors on its Form D filed Jan 13, 2021. This is cumulative sales since the offering began, not current assets or performance.
Where is Phoenix BioMedical Campus Phase I REIT, LLC based?
Phoenix BioMedical Campus Phase I REIT, LLC is based in Chicago, Illinois.
When did Phoenix BioMedical Campus Phase I REIT, LLC launch?
Phoenix BioMedical Campus Phase I REIT, LLC reports its first sale in Jan 2021.
Size compared with every real estate fund
Raised more than 43% of the 477 real estate funds based in Illinois, and more than 8% of all 7,351 that report sales.